Q1 2025 · 13F-HR
Euclidean Capital LLCholdings as filed
Filed 2025-05-15 · accession 0001012975-25-000241
$266.1M
Reported value
11
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 46429B598 | INDA | ISHARES TR | $124.8M | 46.9% | 2,425,144 | Common | SOLE |
| 922042775 | VEU | VANGUARD INTL EQUITY INDEX F | $120.8M | 45.4% | 1,991,884 | Common | SOLE |
| 344174107 | FHTX | FOGHORN THERAPEUTICS INC | $5.7M | 2.16% | 1,573,761 | Common | SOLE |
| 68622P109 | ORIC | ORIC PHARMACEUTICALS INC | $5.5M | 2.07% | 989,410 | Common | SOLE |
| 69353Y103 | PMVP | PMV PHARMACEUTICALS INC | $2.9M | 1.08% | 2,627,643 | Common | SOLE |
| 78462F103 | SPY | SPDR S&P 500 ETF TR | $2.3M | 0.86% | 4,104 | Common | SOLE |
| 014442107 | ALEC | ALECTOR INC | $1.6M | 0.60% | 1,307,858 | Common | SOLE |
| 86889P208 | SRZN | SURROZEN INC | $1.0M | 0.38% | 87,696 | Common | SOLE |
| 75382E109 | — | RAPT THERAPEUTICS INC | $802,637 | 0.30% | 657,899 | Common | SOLE |
| 87990A106 | TNYA | TENAYA THERAPEUTICS INC | $579,053 | 0.22% | 1,015,705 | Common | SOLE |
| 86889P117 | SRZNW | SURROZEN INC | $5,125 | 0.00% | 170,833 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.